Business Context and Reporting Period
Company: Benchmark Electronics, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2001
Industry: Electronics Manufacturing Services (EMS) providing design and manufacturing for telecommunications, computers, and medical devices.
Operations: 14 manufacturing facilities across the Americas, Europe, and Asia.
Key Financial Metrics
| Metric (in thousands) | Q3 2001 | Q3 2000 | 9 Months 2001 | 9 Months 2000 |
|---|---|---|---|---|
| Sales | $257,969 | $459,540 | $1,007,307 | $1,215,266 |
| Gross Profit | $18,898 | $33,900 | $73,113 | $87,250 |
| Gross Margin % | 7.3% | 7.4% | 7.3% | 7.2% |
| Operating Income (Loss) | $(59,106) | $15,281 | $(44,774) | $36,198 |
| Net Income (Loss) | $(57,015) | $6,236 | $(53,996) | $11,819 |
| Diluted EPS | $(2.90) | $0.32 | $(2.75) | $0.65 |
| Cash from Operations (9mo) | $101,306 (vs. $(25,159) in 2000) | |||
| Cash & Equivalents (Sep 30, 2001) | $24,008 | |||
| Total Debt (Sep 30, 2001) | $180,795 (Current + Long-term) |
Material Changes vs. Prior Period
- Revenue Decline: Sales dropped 43.9% in Q3 2001 and 17.1% for the nine-month period compared to 2000. This is attributed to a severe downturn in the technology sector, reduced customer demand, and the sale of Swedish operations in late 2000.
- Significant Asset Write-offs: The company recorded a non-cash asset write-off of $61.7 million in Q3 2001. This included $28.0 million for property, plant, and equipment due to facility consolidation and $33.7 million for goodwill and intangibles.
- Restructuring Charges: Total restructuring charges for the nine months ended September 30, 2001, were $5.1 million, primarily for severance and facility consolidation.
- Working Capital Improvement: Despite the loss, operating cash flow turned positive ($101.3 million for 9 months) due to a significant reduction in accounts receivable ($98.1 million decrease) and inventories ($105.8 million decrease).
- Debt Reduction: The company reduced borrowings under its revolving line of credit by $65.5 million and made $14.8 million in principal payments on long-term debt during the first nine months of 2001.
Guidance, Outlook, and Risks
- Outlook: Management anticipates Q4 2001 sales to be consistent with, or slightly below or above, Q3 2001 levels. Gross margins are expected to fluctuate based on facility utilization and product mix.
- Liquidity: Management believes existing cash, operating funds, and the $146.6 million available under the revolving credit facility are sufficient for the next 9-12 months.
- Accounting Changes: The company is preparing to adopt SFAS No. 142 (Goodwill) effective January 1, 2002, which will stop goodwill amortization but require annual impairment testing. A transitional impairment test is required upon adoption.
- Legal Contingencies:
- Class Action Lawsuits: Pending suits regarding Q3 1999 earnings disclosures; damages are unspecified.
- AVEX Acquisition Dispute: Litigation with J.M. Huber Corporation regarding the 1999 acquisition; damages unspecified.
- Patent Infringement: Lawsuit by Lemelson Foundation regarding machine vision technology; currently stayed pending other judgments.
- Customer Concentration: The two largest customers accounted for 35.7% of sales in the first nine months of 2001.
Investor Verification Checklist
- Asset Impairment Validity: Verify the methodology and fair value assumptions used for the $61.7 million asset write-off and goodwill impairment.
- Inventory Valuation: Confirm the adequacy of the obsolescence reserve ($9.4 million) given the sharp decline in sales volume and technology sector downturn.
- Debt Covenants: Review the impact of the current loss position on financial covenants within the Term Loan and Revolving Credit Facility agreements.
- Customer Concentration Risk: Assess the stability of the top two customers (35.7% of sales) and the risk of order cancellations.
- Future Goodwill Testing: Monitor the upcoming SFAS No. 142 transitional impairment test results, which could trigger further non-cash charges in 2002.